Jane Street’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History

Jane Street’s Portfolio EFTR Stock Details EFTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-18,669	Closed	-$5.42K	–	10743
2024 Q2	$5.42K	Buy	+18,669	New	+$44.3K	﹤0.01%	9158
2021 Q4	–	Sell	-732	Closed	-$257K	–	10972
2021 Q3	$257K	Sell	732 -433	-37%	-$140K	﹤0.01%	8463
2021 Q2	$288K	Buy	1,165 +153	+15%	+$37.6K	﹤0.01%	8215
2021 Q1	$245K	Buy	+1,012	New	+$248K	﹤0.01%	7988

Other funds holding EFTR

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Jane Street's EFTR Position: Q3 2024 in Review

Jane Street sold out of eFFECTOR Therapeutics, Inc. Common Stock (EFTR) in Q3 2024, closing a stake of 18,669 shares — an estimated $5.42K sold.

Jane Street first reported a position in EFTR in Q1 2021 and held it in 4 quarters. The position peaked at $288K in Q2 2021. 3 funds tracked by Wall St. Rank hold EFTR as of Q3 2024.

Jane Street reported no remaining eFFECTOR Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Jane Street sold 18,669 eFFECTOR Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $5.42K.
Jane Street first reported a position in eFFECTOR Therapeutics, Inc. Common Stock in Q1 2021 and held it in 4 quarters.
Jane Street's eFFECTOR Therapeutics, Inc. Common Stock position peaked at $288K in Q2 2021.
3 funds tracked by Wall St. Rank held eFFECTOR Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Jane Street's 13F filing for Q3 2024, filed 15 Nov 2024.